Dual antiplatelet pre-treatment with aspirin and ticagrelor in ACS patients undergoing unplanned aortocoronary bypass surgery
Need of urgent CABG in ACS is infrequent and does not result in an excess of mortality. However, cessation of ticagrelor for at least 48 h before CABG is recommended to minimize rates of CABG-related bleedings.
Authors
- Norbert Frey (ORCID: https://orcid.org/0000-0001-7611-378X)
- Christian Salbach (ORCID: https://orcid.org/0000-0002-1799-545X)
- Barbara Ruth Milles (ORCID: https://orcid.org/0009-0004-4602-5489)
- Evangelos Giannitsis (ORCID: https://orcid.org/0000-0002-1025-2872)
- Matthias Mueller‐Hennessen
- Moritz Biener (ORCID: https://orcid.org/0000-0001-6763-6538)
- Hauke Hund
- Mustafa Yıldırım (ORCID: https://orcid.org/0000-0001-8564-2958)
- Rebecca Gulba
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1007/s00392-025-02629-0
- Citations
- 1
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Universitätsklinikum Heidelberg